AGOPTON caps 15 mg 28 pce

7680519690577 CH-51969 A02BC03 04.99.0.

Active substances:

AGOPTON caps 15 mg 28 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5196902
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
lansoprazolum 15 mg, magnesii subcarbonas ponderosus, sacchari sphaerae, saccharum, maydis amylum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas, macrogolum 8000, E 171, polysorbatum 80, talcum, silica colloidalis anhydrica, Kapselhülle: gelatina, aqua, E 171, pro capsula corresp. natrium max. 0.02 mg et saccharum max. 80.3 mg.

Articles (1)

Agopton 15 mg, magensaftresistente Hartkapseln
Magensaftresistente Hartkapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/09/2026
Patient information leaflet
Français
09/09/2026
Patient information leaflet
Italien
09/09/2026
Professional SmPC
Allemand
04/08/2026
Professional SmPC
Français
04/08/2026
Professional SmPC
Italien
04/08/2026

Detailed composition

Substance Quantity Type Category
lansoprazolum
15.0 MG Substance Wirkstoff (Principe actif)
magnesii subcarbonas ponderosus
- Substance HNIDK
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HNIDK
maydis amylum
- Substance HNIDK
hydroxypropylcellulosum substitutum humile
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 8000
- Substance HNIDK
E 171
- Substance FNIDK
polysorbatum 80
- Substance HNIDK
talcum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
gelatina
- Substance HNIDK
aqua
- Substance HNIDK
E 171
- Substance FNIDK
natrium
- Substance HBESI
saccharum
- Substance HBESI

Reimbursement information

Public price
CHF 27.10
Specialties list
Yes
Generic
No
SL addition date: 15/03/1996

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
51969
Drug name
Agopton, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
A02BC03
Authorization status
Z
Dispensation category
B
First authorization
18/06/1993
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
peptisches Ulcus, gastroösophageale Refluxkrankheit

Packaging details

Description (FR)
AGOPTON caps 15 mg 28 pce
Description (DE)
AGOPTON Kaps 15 mg 28 Stk
Market launch
11/09/1995
Narcotic (BTM)
No

Available generics

Lansoprazol-Mepha, Kapseln
CHF 36.35
View
Lansoprazol-Mepha, Kapseln
CHF 46.35
View
Lansoprazol-Mepha, Kapseln
CHF 14.80
View
Lansoprazol-Mepha, Kapseln
CHF 26.60
View
Lansoprazol-Mepha, Kapseln
CHF 35.05
View
Lansoprazol-Mepha, Kapseln
CHF 49.75
View
Lansoprazol-Mepha, Kapseln
CHF 46.45
View
Lansoprazol-Mepha, Kapseln
CHF 26.00
View
Lansoprazol-Mepha, Kapseln
CHF 33.20
View
Lansoprazol-Mepha, Kapseln
CHF 44.55
View

Other packaging sizes

AGOPTON caps 30 mg 14 pce
14 KAP
View
AGOPTON caps 30 mg 28 pce
28 KAP
View
AGOPTON caps 30 mg 56 pce
56 KAP
View
AGOPTON caps 15 mg 14 pce
14 KAP
View
AGOPTON caps 15 mg 56 pce
56 KAP
View
AGOPTON caps 15 mg 112 pce
112 KAP
View
Buy us a coffee Explore the data